810 NX-1607, a small molecule inhibitor of CBL-B, enhances anti-PD-1-mediated tumor growth inhibition by reshaping intratumoral innate and adaptive immune response

• Ernestine Lee,
• Alexandra Borodovsky,
• Marilena Gallotta,
• Jose Gomez Romo,
• Serena Ranucci,
• Gwenn M Hansen,
• Arthur T Sands,
• Ryan Rountree,
• Cristiana Guiducci

Affiliations

Ernestine Lee

2Five Prime Therapeutics, Inc., South San Francisco, CA, USA

Alexandra Borodovsky

1Nurix Therapeutics, San Francisco, CA, USA

Marilena Gallotta

1Nurix Therapeutics, San Francisco, CA, USA

Jose Gomez Romo

1Nurix Therapeutics, San Francisco, CA, USA

Serena Ranucci

1Nurix Therapeutics, San Francisco, CA, USA

Gwenn M Hansen

1Nurix Therapeutics, San Francisco, CA, USA

Arthur T Sands

1Nurix Therapeutics, San Francisco, CA, USA

Ryan Rountree

1Nurix Therapeutics, San Francisco, CA, USA

Cristiana Guiducci

1Nurix Therapeutics, San Francisco, CA, USA